Dimensional Fund Advisors’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$4.79M Buy
239,874
+147,946
+161% +$1.95M ﹤0.01% 2439
2022
Q2
$633K Sell
91,928
-29,767
-24% -$209K ﹤0.01% 3017
2022
Q1
$1.13M Buy
121,695
+7,859
+7% +$83.7K ﹤0.01% 2965
2021
Q4
$1.62M Buy
113,836
+60,984
+115% +$1.06M ﹤0.01% 2903
2021
Q3
$1.23M Buy
+52,852
New +$1.25M ﹤0.01% 2997

Other funds holding FMTX

Dimensional Fund Advisors's FMTX Position: Q3 2022 in Review

Dimensional Fund Advisors increased its Forma Therapeutics Holdings, Inc. Common Stock (FMTX) stake by 161% in Q3 2022, buying an estimated $1.95M and bringing the position to 239,874 shares worth $4.79M. The position accounts for ﹤0.01% of the portfolio, ranked #2439.

Dimensional Fund Advisors first reported a position in FMTX in Q3 2021 and has held it in 5 quarters since. 139 funds tracked by Wall St. Rank hold FMTX as of Q3 2022.

  • Dimensional Fund Advisors held 239,874 shares of Forma Therapeutics Holdings, Inc. Common Stock worth $4.79M as of Q3 2022.
  • Dimensional Fund Advisors bought 147,946 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $1.95M.
  • Forma Therapeutics Holdings, Inc. Common Stock made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q3 2022, its #2439 holding.
  • Dimensional Fund Advisors first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2021 and has held it in 5 quarters since.
  • 139 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Dimensional Fund Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.